Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: J Clin Pharmacol. 2019 Aug 29;60(2):264–273. doi: 10.1002/jcph.1522

Figure 2.

Figure 2.

A single IV dose of BNZ-1 was administered over ≤5 minutes starting at time = 0, day 1. PK samples were collected at 0.08, 0.5, 1, 2, 4, 8, and 24 hours after dosing, and on days 4, 6, 8, 15, 22, and 31. The plot shows the average plasma concentration at each time point (n = 3). The upper figure represents the distribution phase (up to 24 hours), and the lower figure shows the elimination phase (days 2–36). IV, intravenous; PK, pharmacokinetic.